Active
A phase 2 study of OSI-906 in pediatic and adult wild type gastrointestinal stromal tumors
Type of Sarcoma:
gastrointestinal stromal tumors
Drug:
OSI-906
Accrual Status:
Open, Not Accruing
Overall Study Principal Investigator:
Margaret von Mehren, MD
Fox Chase Cancer Center